Ultragenyx Pharmaceutical
RARE
#3271
Rank
S$4.42 B
Marketcap
$47.08
Share price
1.44%
Change (1 day)
-20.87%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2023 (TTM): -$14.05

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$13.43. In 2022 the company made an earnings per share (EPS) of -$13.26 a decrease over its 2021 EPS that were of -$8.80.

EPS history for Ultragenyx Pharmaceutical from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$14.055.99%
2022-$13.2650.67%
2021-$8.80113.69%
2020-$4.12-55.9%
2019-$9.3482.56%
2018-$5.11-45.15%
2017-$9.3214.68%
2016-$8.1357.36%
2015-$5.1769.83%
2014-$3.0415.22%
2013-$2.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.02-107.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.84-93.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.70-72.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.89-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA